~~<i id='7BF4D30488'><strike id='7BF4D30488'><tt id='7BF4D30488'><pre id='7BF4D30488'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：focus 2025-09-27 23:03:25 - browse：29958

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： EU regulator recommends expanding Mounjaro approval to obesity

knowledge

focus

hotspot

knowledge

Wikipedia

focus

AdobeResearchuniversitiesarevoicingconcernsoversomeproposedchangestotheprocessforreviewingscientific

WSS

Elizabeth Holmes banned from government health programs

New brain studies show LSD's effects on the brain in full color

Eli Lilly, Pfizer, and others want in on the online prescription market

Test for long Covid? Researchers find new clue in blood samples

Chemotherapy drug shortage eases slightly but still widespread

Prior authorization will have to move faster under new Biden rule

focus

hotspot

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

How digital therapeutics firms are pivoting after Pear's bankruptcy

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Trump demands the U.S. pay no more for drugs than other countries … again

Liquid biopsy for lung cancer is launched by Delfi

23andMe had bad news about my health. I wish a person had delivered it

FDA clears AI tool for detecting skin cancer

Apple is now the first public company to be valued at $3 trillion

AI can decode, harness the power of the humane immune system

focus

Bristol 'take

Phenylephrine and the overlooked value of the placebo effect

A virus, fished out of a lake, may have saved a man’s life

Humana cuts profit projections as Medicare Advantage costs soar

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

The surgeon had a dilemma only a Nazi medical text could resolve

hotspot

knowledge

Wikipedia

focus